141 related articles for article (PubMed ID: 37470935)
1. Differential Protein Expression in Response to Varlitinib Treatment in Oral Cancer Cell Line: an In Vitro Therapeutic Approach.
Tanveer F; Ilyas A; Syed B; Hashim Z; Ahmed A; Zarina S
Appl Biochem Biotechnol; 2024 Apr; 196(4):2110-2121. PubMed ID: 37470935
[TBL] [Abstract][Full Text] [Related]
2. β-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma.
Chandler KB; Alamoud KA; Stahl VL; Nguyen BC; Kartha VK; Bais MV; Nomoto K; Owa T; Monti S; Kukuruzinska MA; Costello CE
Mol Omics; 2020 Jun; 16(3):195-209. PubMed ID: 32203567
[TBL] [Abstract][Full Text] [Related]
3. Lupeol evokes anticancer effects in oral squamous cell carcinoma by inhibiting oncogenic EGFR pathway.
Rauth S; Ray S; Bhattacharyya S; Mehrotra DG; Alam N; Mondal G; Nath P; Roy A; Biswas J; Murmu N
Mol Cell Biochem; 2016 Jun; 417(1-2):97-110. PubMed ID: 27206736
[TBL] [Abstract][Full Text] [Related]
4. Combinatorial treatment with Gefitinib and Bay11-7085 sensitizes primary Gefitinib-resistant OSCC cells by influencing the EGFR- NFκB signaling axis.
Sinto MS; Thomas S; Kannan S
Med Oncol; 2021 Aug; 38(9):110. PubMed ID: 34357463
[TBL] [Abstract][Full Text] [Related]
5. Decreased GRP78 protein expression is a potential prognostic marker of oral squamous cell carcinoma in Taiwan.
Huang TT; Chen JY; Tseng CE; Su YC; Ho HC; Lee MS; Chang CT; Wong YK; Chen HR
J Formos Med Assoc; 2010 May; 109(5):326-37. PubMed ID: 20497865
[TBL] [Abstract][Full Text] [Related]
6. EGFR-mediated signaling pathway influences the sensitivity of oral squamous cell carcinoma to JQ1.
Liu X; Li Q; Huang P; Tong D; Wu H; Zhang F
J Cell Biochem; 2018 Oct; 119(10):8368-8377. PubMed ID: 30687956
[TBL] [Abstract][Full Text] [Related]
7. A potential link between desmoglein 3 and epidermal growth factor receptor in oral squamous cell carcinoma and its effect on cetuximab treatment efficacy.
Minabe M; Akiyama Y; Higa K; Tachikawa T; Takahashi S; Nomura T; Kouno M
Exp Dermatol; 2019 May; 28(5):614-617. PubMed ID: 30907457
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor inhibitors enhance susceptibility to Fas-mediated apoptosis in oral squamous cell carcinoma cells.
Iwase M; Takaoka S; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M
Oral Oncol; 2008 Apr; 44(4):361-8. PubMed ID: 17689285
[TBL] [Abstract][Full Text] [Related]
9. Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS.
Chi LM; Lee CW; Chang KP; Hao SP; Lee HM; Liang Y; Hsueh C; Yu CJ; Lee IN; Chang YJ; Lee SY; Yeh YM; Chang YS; Chien KY; Yu JS
Mol Cell Proteomics; 2009 Jul; 8(7):1453-74. PubMed ID: 19297561
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
[TBL] [Abstract][Full Text] [Related]
11. EGFR inhibitor enhances cisplatin sensitivity of oral squamous cell carcinoma cell lines.
Hiraishi Y; Wada T; Nakatani K; Tojyo I; Matsumoto T; Kiga N; Negoro K; Fujita S
Pathol Oncol Res; 2008 Mar; 14(1):39-43. PubMed ID: 18347929
[TBL] [Abstract][Full Text] [Related]
12. IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling.
Pidugu VK; Wu MM; Yen AH; Pidugu HB; Chang KW; Liu CJ; Lee TC
Oncogene; 2019 Apr; 38(17):3232-3247. PubMed ID: 30626937
[TBL] [Abstract][Full Text] [Related]
13. FBLIM1 enhances oral cancer malignancy via modulation of the epidermal growth factor receptor pathway.
Toeda Y; Kasamatsu A; Koike K; Endo-Sakamoto Y; Fushimi K; Kasama H; Yamano Y; Shiiba M; Tanzawa H; Uzawa K
Mol Carcinog; 2018 Dec; 57(12):1690-1697. PubMed ID: 30129678
[TBL] [Abstract][Full Text] [Related]
14. YAP-Dependent BiP Induction Is Involved in Nicotine-Mediated Oral Cancer Malignancy.
Chien CY; Chen YC; Hsu CC; Chou YT; Shiah SG; Liu SY; Hsieh AC; Yen CY; Lee CH; Shieh YS
Cells; 2021 Aug; 10(8):. PubMed ID: 34440849
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines.
Dokduang H; Jamnongkarn W; Promraksa B; Suksawat M; Padthaisong S; Thanee M; Phetcharaburanin J; Namwat N; Sangkhamanon S; Titapun A; Khuntikeo N; Klanrit P; Loilome W
Drug Des Devel Ther; 2020; 14():2319-2334. PubMed ID: 32606601
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
Cai Z; Hao XY; Liu FX
Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
[TBL] [Abstract][Full Text] [Related]
17. A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway.
Huang WC; Jang TH; Tung SL; Yen TC; Chan SH; Wang LH
J Exp Clin Cancer Res; 2019 Feb; 38(1):89. PubMed ID: 30782177
[TBL] [Abstract][Full Text] [Related]
18. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
[TBL] [Abstract][Full Text] [Related]
19. Epidermal Growth Factor (EGF) Autocrine Activation of Human Platelets Promotes EGF Receptor-Dependent Oral Squamous Cell Carcinoma Invasion, Migration, and Epithelial Mesenchymal Transition.
Chen R; Jin G; Li W; McIntyre TM
J Immunol; 2018 Oct; 201(7):2154-2164. PubMed ID: 30150285
[TBL] [Abstract][Full Text] [Related]
20. Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?
Grimm M; Cetindis M; Lehmann M; Biegner T; Munz A; Teriete P; Kraut W; Reinert S
J Transl Med; 2014 Jul; 12():208. PubMed ID: 25048361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
